Michael Atef Fawzy
Overview
Explore the profile of Michael Atef Fawzy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fahim J, Samy M, Ibrahem E, Fawzy M, Saber E, Kamel M, et al.
Fitoterapia
. 2025 Mar;
182:106466.
PMID: 40058657
Hepatic fibrosis is a major health concern that can develop into other life-threatening pathologies, with no fully effective treatments are available to date. Ceiba is a genus of multipurpose trees...
2.
Fawzy M, Ibrahim K, Aly A, Mohamed A, Abdel Hafez S, Abdelzaher W, et al.
Future Med Chem
. 2024 Sep;
16(21):2211-2230.
PMID: 39291539
Pulmonary fibrosis is a life threating disease which requires an immediate treatment and due to the limited medications, this study focused on synthesizing a series of quinoline-based pyrimidodiazepines as a...
3.
Geddawy A, Attya M, Hegazy A, AbdElhaseeb M, Fawzy M, Atta M, et al.
Mol Biol Rep
. 2024 May;
51(1):655.
PMID: 38739285
Background: There is limited data regarding the hazardous effect of gentamicin (GM) on the uterus and whether or not vinpocetine (Vinpo) ameliorates it. The present study aimed to identify the...
4.
Refaie M, Shehata S, El-Hussieny M, Fawzy M, Ahmed N, Marey H, et al.
Toxicol Res
. 2024 Jan;
40(1):139-151.
PMID: 38223670
Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-023-00204-1.
5.
Abdelzaher W, Abdel-Gaber S, Fawzy M, Hamid Sayed Abo Bakr Ali A, Attya M, Geddawy A
Int Immunopharmacol
. 2023 Oct;
124(Pt B):111061.
PMID: 37844467
Background: Cancer chemotherapy is associated with various tissue toxicities that limit its use. Cyclophosphamide (CYC) is one of the most commonly used antineoplastic and immunosuppressive agent. Thyroid dysfunction is a...
6.
Refaie M, Ibrahim M, Fawzy M, Abdel-Hakeem E, Rahman E, Zenhom N, et al.
Immunopharmacol Immunotoxicol
. 2023 Jun;
45(6):650-662.
PMID: 37335038
Background: Myocardial necrosis is one of the most common cardiac and pathological diseases. Unfortunately, using the available medical treatment is not sufficient to rescue the myocardium. So that, we aimed...
7.
Ali D, Mahmoud M, Rifaai R, Fawzy M, Atta M, Welson N, et al.
J Cell Mol Med
. 2023 May;
27(12):1735-1744.
PMID: 37257043
The present study aimed to identify the possible protective effect of diacerein (DIA) on gentamicin (GNT)-induced parotid toxicity in rats. DIA was administered in the presence and absence of GNT....
8.
Refaie M, Rifaai R, Fawzy M, Shehata S
Cardiovasc Toxicol
. 2023 Mar;
23(3-4):176.
PMID: 36857015
No abstract available.
9.
Abdelzaher W, Ibrahim M, Hassan M, Gamal El-Tahawy N, Fawzy M, Hafez H
Chem Biol Interact
. 2023 Feb;
373:110399.
PMID: 36774993
Background: Early diagnosis and treatment of endometrial hyperplasia (EH) remains mandatory for endometrial cancer (EC) prevention. Objective: To study the possible protective effect of eicosapentaenoic acid (EPA) in EH -...
10.
Refaie M, Rifaai R, Fawzy M, Shehata S
Cardiovasc Toxicol
. 2022 Oct;
22(10-11):916-928.
PMID: 36242756
Cadmium (Cd) is a common environmental pollutant that leads to severe cardiotoxic hazards. Several studies were carried out to protect the myocardium against Cd-induced cardiotoxicity. Up till now, no researches...